Chong Kun Dang Pharmaceutical

Chong Kun Dang Pharmaceutical

World Rank (Jan-05-2024)
7,532
Market Cap (Jan-05-2024)
1.252 Billion USD
World Rank (Jul-30-2023)
10,251
Market Cap (Jul-30-2023)
0.755 Billion USD
World Rank (Jan-07-2022)
9,238
Market Cap (Jan-07-2022)
1.025 Billion USD
World Rank (Jan-01-2021)
8,177
Headquarters Country
South Korea
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
1,005 Million USD
Annual Net Income in USD
32 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
783 Million USD
Total Liabilities in USD
360 Million USD
Total Equity in USD
423 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
CHONG KUN DANG PHARMACEUTICAL
Yahoo
Yahoo @ SouthKorea
Company Profile
Chong Kun Dang Pharmaceutical is a Korean pharmaceutical company focused on the raw materials required for medicines from abroad. The company annual revenue is 1,343,559 million KRW and annual net income is 42,720 million KRW for year ending December 2021. The headquarters is in South Korea.
Stock Exchange
South Korea

Share